Trivitron Healthcare

Trivitron does not publicly name its executive team, board, or investment decision-makers. The firm's website and the public record offer no named principals as of mid-2026.

Trivitron designs and distributes medical diagnostic equipment and consumables — including newborn screening kits, automated IVD analyzers, patient monitors, ventilators, and AI radiology tools — primarily for public health systems and hospitals in low-resource settings across 180+ countries.

The firm's website emphasizes 'integrated, adaptable technology' and 'research-backed reagents,' but does not specify whether manufacturing is in-house or outsourced. The company describes a 'one ecosystem' model spanning prevention to recovery.

Trivitron reports operations in 180+ countries with headquarters in Chennai, India. The firm's public site mentions national screening programs and 'remote communities' globally, but does not list specific regional offices or distribution hubs.

Trivitron does not disclose its ownership structure, institutional investors, or any family-office affiliation. The firm presents itself as a standalone operating company; no public records indicate funding rounds, venture capital, or private equity backing.

Yes — Trivitron's website lists AI solutions for radiology image enhancement and predictive lab analytics, described as 'clinically validated tools' integrated into daily clinical workflows. No specific product names or deployment numbers are published.

Trivitron states it reaches 180+ countries through portable, eco-efficient systems. The firm's website emphasizes distribution to 'resource-limited settings' and national screening programs, but does not disclose direct sales, partnerships, or distributor networks in specific markets.